Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny

Dec 1, 2024
by Prosper Junior Bakiny
2 Dividend Stocks to Buy and Hold Forever

Nov 25, 2024
by Prosper Junior Bakiny
1 Stock to Avoid After the Election Results

Nov 21, 2024
by Prosper Junior Bakiny
Is Bristol Myers Squibb Stock a Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.